Deficiency of Interleukin-1 Receptor Antagonist Deteriorates Fatty Liver and Cholesterol Metabolism in Hypercholesterolemic Mice
Open Access
- 1 February 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (8) , 7002-7009
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- IL-1 Plays an Important Role in Lipid Metabolism by Regulating Insulin Levels under Physiological ConditionsJournal of Experimental Medicine, 2003
- Tumor Necrosis Factor α-dependent Up-regulation of Lrh-1 and Mrp3(Abcc3) Reduces Liver Injury in Obstructive CholestasisJournal of Biological Chemistry, 2003
- Endothelial Cells Secrete Triglyceride Lipase and Phospholipase Activities in Response to Cytokines as a Result of Endothelial LipaseCirculation Research, 2003
- Cytokines in Alcoholic Liver DiseaseSeminars in Liver Disease, 1999
- Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid SecretionJournal of Experimental Medicine, 1998
- Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor AntagonistInternational Reviews of Immunology, 1998
- An oxysterol signalling pathway mediated by the nuclear receptor LXRαNature, 1996
- Effects of endotoxin and cytokines on lipid metabolismCurrent Opinion in Lipidology, 1994
- Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice.Journal of Clinical Investigation, 1993
- Variation in susceptibility to atherosclerosis among inbred strains of miceAtherosclerosis, 1985